Table 2:

Perioperative variables

VariablesTotalRVPACMBTSP value
335164 (49.0)171 (51.0)
Norwood procedure, median (IQR)
 Age at Norwood (days)8 (7–12)8 (7–11)9 (7–12)0.026
 Weight at Norwood (kg)3.2 (2.9–3.5)3.2 (2.9–3.5)3.2 (2.8–3.5)0.130
 CPB time (min)138 (109–165)135 (105–163)141 (110–167)0.455
 AXC time (min)49 (41–59)47 (41–57)49 (40–60)0.406
Postoperative variables
 Intubation (days), median (IQR)5 (4–9)6 (4–13)5 (3–8)0.351
 ICU stay (days), median (IQR)13 (8–21)14 (10–22)12 (8–20)0.663
 HSP stay (days), median (IQR)24 (15–37)25 (18–37)23 (14–40)0.234
 ECMO, n (%)46 (13.8)23 (14.0)23 (13.5)0.896
 Re-intubation, n (%)56 (16.8)25 (15.3)31 (18.2)0.480
 Shunt intervention, n (%)50 (15.0)29 (17.7)21 (12.4)0.179
 Re CoA intervention, n (%)19 (5.7)10 (6.1)9 (5.3)0.761
 Peritoneal dialysis, n (%)40 (11.9)25 (15.2)15 (8.8)0.068
 Necrotizing enterocolitis, n (%)22 (6.6)7 (4.3)15 (8.8)0.099
VariablesTotalRVPACMBTSP value
335164 (49.0)171 (51.0)
Norwood procedure, median (IQR)
 Age at Norwood (days)8 (7–12)8 (7–11)9 (7–12)0.026
 Weight at Norwood (kg)3.2 (2.9–3.5)3.2 (2.9–3.5)3.2 (2.8–3.5)0.130
 CPB time (min)138 (109–165)135 (105–163)141 (110–167)0.455
 AXC time (min)49 (41–59)47 (41–57)49 (40–60)0.406
Postoperative variables
 Intubation (days), median (IQR)5 (4–9)6 (4–13)5 (3–8)0.351
 ICU stay (days), median (IQR)13 (8–21)14 (10–22)12 (8–20)0.663
 HSP stay (days), median (IQR)24 (15–37)25 (18–37)23 (14–40)0.234
 ECMO, n (%)46 (13.8)23 (14.0)23 (13.5)0.896
 Re-intubation, n (%)56 (16.8)25 (15.3)31 (18.2)0.480
 Shunt intervention, n (%)50 (15.0)29 (17.7)21 (12.4)0.179
 Re CoA intervention, n (%)19 (5.7)10 (6.1)9 (5.3)0.761
 Peritoneal dialysis, n (%)40 (11.9)25 (15.2)15 (8.8)0.068
 Necrotizing enterocolitis, n (%)22 (6.6)7 (4.3)15 (8.8)0.099

AA: aortic atresia; AS: aortic stenosis; AXC: aortic cross clamp; CoA: coarctation of the aorta; CPB: cardiopulmonary bypass; DILV: double inlet left ventricle; ECMO: extracorporeal membrane oxygenation; HSP: hospital; ICU: intensive care unit; IQR: interquartile range; MA: mitral atresia; MBTS: modified Blalock–Taussig shunt; MS: mitral stenosis; RVPAC: right ventricle to pulmonary artery conduit; SV: single ventricle; TA: tricuspid atresia; TAPVC: total anomalous pulmonary venous connection; UAVSD: unbalanced atrioventricular septal defect.

Table 2:

Perioperative variables

VariablesTotalRVPACMBTSP value
335164 (49.0)171 (51.0)
Norwood procedure, median (IQR)
 Age at Norwood (days)8 (7–12)8 (7–11)9 (7–12)0.026
 Weight at Norwood (kg)3.2 (2.9–3.5)3.2 (2.9–3.5)3.2 (2.8–3.5)0.130
 CPB time (min)138 (109–165)135 (105–163)141 (110–167)0.455
 AXC time (min)49 (41–59)47 (41–57)49 (40–60)0.406
Postoperative variables
 Intubation (days), median (IQR)5 (4–9)6 (4–13)5 (3–8)0.351
 ICU stay (days), median (IQR)13 (8–21)14 (10–22)12 (8–20)0.663
 HSP stay (days), median (IQR)24 (15–37)25 (18–37)23 (14–40)0.234
 ECMO, n (%)46 (13.8)23 (14.0)23 (13.5)0.896
 Re-intubation, n (%)56 (16.8)25 (15.3)31 (18.2)0.480
 Shunt intervention, n (%)50 (15.0)29 (17.7)21 (12.4)0.179
 Re CoA intervention, n (%)19 (5.7)10 (6.1)9 (5.3)0.761
 Peritoneal dialysis, n (%)40 (11.9)25 (15.2)15 (8.8)0.068
 Necrotizing enterocolitis, n (%)22 (6.6)7 (4.3)15 (8.8)0.099
VariablesTotalRVPACMBTSP value
335164 (49.0)171 (51.0)
Norwood procedure, median (IQR)
 Age at Norwood (days)8 (7–12)8 (7–11)9 (7–12)0.026
 Weight at Norwood (kg)3.2 (2.9–3.5)3.2 (2.9–3.5)3.2 (2.8–3.5)0.130
 CPB time (min)138 (109–165)135 (105–163)141 (110–167)0.455
 AXC time (min)49 (41–59)47 (41–57)49 (40–60)0.406
Postoperative variables
 Intubation (days), median (IQR)5 (4–9)6 (4–13)5 (3–8)0.351
 ICU stay (days), median (IQR)13 (8–21)14 (10–22)12 (8–20)0.663
 HSP stay (days), median (IQR)24 (15–37)25 (18–37)23 (14–40)0.234
 ECMO, n (%)46 (13.8)23 (14.0)23 (13.5)0.896
 Re-intubation, n (%)56 (16.8)25 (15.3)31 (18.2)0.480
 Shunt intervention, n (%)50 (15.0)29 (17.7)21 (12.4)0.179
 Re CoA intervention, n (%)19 (5.7)10 (6.1)9 (5.3)0.761
 Peritoneal dialysis, n (%)40 (11.9)25 (15.2)15 (8.8)0.068
 Necrotizing enterocolitis, n (%)22 (6.6)7 (4.3)15 (8.8)0.099

AA: aortic atresia; AS: aortic stenosis; AXC: aortic cross clamp; CoA: coarctation of the aorta; CPB: cardiopulmonary bypass; DILV: double inlet left ventricle; ECMO: extracorporeal membrane oxygenation; HSP: hospital; ICU: intensive care unit; IQR: interquartile range; MA: mitral atresia; MBTS: modified Blalock–Taussig shunt; MS: mitral stenosis; RVPAC: right ventricle to pulmonary artery conduit; SV: single ventricle; TA: tricuspid atresia; TAPVC: total anomalous pulmonary venous connection; UAVSD: unbalanced atrioventricular septal defect.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close